Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Bower

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Protein Expression and Purification|February 1, 2017
A fully automated procedure for the parallel, multidimensional purification and nucleotide loading of the human GTPases KRas, Rac1 and RalBChristopher H Gray, Jennifer Konczal, Mokdad Mezna, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2003
Structure-based design of agents targeting the bacterial ribosomeJustin Bower, Martin Drysdale, Richard Hebdon, et al.
Chemical Communications (Cambridge, England)|February 6, 2014
The first intramolecular silene Diels-Alder reactionsMichal Czyzewski, Jonathan D Sellars, Tamaz Guliashvili, et al.
Neoplasia (New York, N.Y.)|October 18, 2015
Identification of a Selective G1-Phase Benzimidazolone Inhibitor by a Senescence-Targeted Virtual Screen Using Artificial Neural NetworksAlan E Bilsland, Angelo Pugliese, Yu Liu, et al.
Journal of Molecular Biology|February 6, 2004
Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots"Ben Davis, Mohammad Afshar, Gabriele Varani, et al.
Cell Communication and Signaling : CCS|October 8, 2014
A novel small-molecule MRCK inhibitor blocks cancer cell invasionMathieu Unbekandt, Daniel R Croft, Diane Crighton, et al.
Journal of Molecular Biology|April 21, 2004
Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNAAlastair I H Murchie, Ben Davis, Catherine Isel, et al.
Drug Discovery Today|August 3, 2013
Fragment-based hit identification: thinking in 3DAndrew D Morley, Angelo Pugliese, Kristian Birchall, et al.
Journal of Medicinal Chemistry|February 2, 2022
Stabilization of the RAS:PDE6D Complex Is a Novel Strategy to Inhibit RAS SignalingTamas Yelland, Esther Garcia, Charles Parry, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2019
Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agentsStuart Francis, Daniel Croft, Alexander W Schüttelkopf, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Protein Expression and Purification|February 1, 2017
A fully automated procedure for the parallel, multidimensional purification and nucleotide loading of the human GTPases KRas, Rac1 and RalBChristopher H Gray, Jennifer Konczal, Mokdad Mezna, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2003
Structure-based design of agents targeting the bacterial ribosomeJustin Bower, Martin Drysdale, Richard Hebdon, et al.
Chemical Communications (Cambridge, England)|February 6, 2014
The first intramolecular silene Diels-Alder reactionsMichal Czyzewski, Jonathan D Sellars, Tamaz Guliashvili, et al.
Neoplasia (New York, N.Y.)|October 18, 2015
Identification of a Selective G1-Phase Benzimidazolone Inhibitor by a Senescence-Targeted Virtual Screen Using Artificial Neural NetworksAlan E Bilsland, Angelo Pugliese, Yu Liu, et al.
Journal of Molecular Biology|February 6, 2004
Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots"Ben Davis, Mohammad Afshar, Gabriele Varani, et al.
Cell Communication and Signaling : CCS|October 8, 2014
A novel small-molecule MRCK inhibitor blocks cancer cell invasionMathieu Unbekandt, Daniel R Croft, Diane Crighton, et al.
Journal of Molecular Biology|April 21, 2004
Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNAAlastair I H Murchie, Ben Davis, Catherine Isel, et al.
Drug Discovery Today|August 3, 2013
Fragment-based hit identification: thinking in 3DAndrew D Morley, Angelo Pugliese, Kristian Birchall, et al.
Journal of Medicinal Chemistry|February 2, 2022
Stabilization of the RAS:PDE6D Complex Is a Novel Strategy to Inhibit RAS SignalingTamas Yelland, Esther Garcia, Charles Parry, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2019
Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agentsStuart Francis, Daniel Croft, Alexander W Schüttelkopf, et al.
Pageof 3